The role operates at the commercial-R&D interface to shape the early hematology pipeline from preclinical through early clinical development
Job Summary
The role operates at the commercial-R&D interface to shape the early hematology pipeline from preclinical through early clinical development.
Candidates must lead early commercial strategies integrating disease biology, competitive dynamics, and customer insights to define target product profiles.
The position offers a base pay range of $270,221 to $405,332 along with short-term incentives and equity-based long-term programs.
Matching Summary
The role operates at the commercial-R&D interface to shape the early hematology pipeline from preclinical through early clinical development.
Salary
Base: $270,221 - $405,332; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program eligible; Benefits: 401(k), paid vacation/holidays, health/dental/vision coverage
Skills & Requirements
Must-have
Hematology commercial strategy
Early asset development planning
Target product profile creation
Clinical trial design input
Market access and pricing strategy
Cross-functional matrix leadership
Nice-to-have
Experience with TCE and ADC modalities
Strong storytelling for senior stakeholders
Network with hematology centers of excellence
Background in small molecule therapies
Advanced degree like MBA or PhD
Key Requirements
MD required with hematology training preferred
10+ years biopharma industry experience
Direct exposure to TCE, ADC, and small molecule modalities
Proven success shaping early asset strategies
Board certification in hematology/oncology advantageous